Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 210934 (Dec 20, 2024)

Issued December 20, 2024

Issued

December 20, 2024

Application

NDA 505b1 • 210934

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due December 20, 2025Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…